Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Zhu, Helen He  [Clear All Filters]
Journal Article
Wang L, Zhang K, Zhu HHe, Gao W-Q. Autonomous assembly of epithelial structures by subrenal implantation of dissociated embryonic inner-ear cells. Neuroreport. 2015;26(8):473-477.
Hui L, Wang D, Liu Z, Zhao Y, Ji Z, Zhang M, Zhu HHe, Luo W, Cheng X, Gui L, et al. The Cell-isolation Capsules with Rod-like Channels Ensure the Survival and Response of Cancer Cells to Their Microenvironment. Adv Healthc Mater. 2021:e2101723.
Guyot B, Clément F, Drouet Y, Schmidt X, Lefort S, Delay E, Treilleux I, Foy J-P, Jeanpierre S, Thomas E, et al. An early neoplasia index (ENI10), based on molecular identity of CD10 cells and associated stemness biomarkers, is a predictor of patient outcome in many cancers. Cancer Res Commun. 2023.
Wang X, Dong B, Zhang K, Ji Z, Cheng C, Zhao H, Sheng Y, Li X, Fan L, Xue W, et al. E-cadherin bridges cell polarity and spindle orientation to ensure prostate epithelial integrity and prevent carcinogenesis in vivo. PLoS Genet. 2018;14(8):e1007609.
Ji Y, Zhang W, Shen K, Su R, Liu X, Ma Z, Liu B, Hu C, Xue Y, Xin Z, et al. The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer. Nat Commun. 2023;14(1):7794.
Wang D, Cheng C, Chen X, Wang J, Liu K, Jing N, Xu P, Xi X, Sun Y, Ji Z, et al. IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer. Adv Sci (Weinh). 2023:e2206889.
Cai Y, Zhu B, Shan X, Zhou L, Sun X, Xia A, Wu B, Yu Y, Zhu HHe, Zhang P, et al. Inhibiting Endothelial Cell-Mediated T Lymphocyte Apoptosis with Integrin-Targeting Peptide-Drug Conjugate Filaments for Chemoimmunotherapy of Triple-Negative Breast Cancer. Adv Mater. 2023:e2306676.
Liu K, Jing N, Wang D, Xu P, Wang J, Chen X, Cheng C, Xin Z, He Y, Zhao H, et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 2021:e13056.
He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X, Miao J, Zhang K, Zhang W, Ma P, et al. Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. Cell Rep. 2023;42(2):112033.
Clément F, Zhu HHe, Gao W-Q, Delay E, Maguer-Satta V. Quantifying Epithelial Early Common Progenitors from Long-Term Primary or Cell Line Sphere Culture. Curr Protoc Stem Cell Biol. 2015;35:1E.7.1-1E.7.8.
Zhang C, Ji Z, Wang M, Zhang W, Yang R, An H, Yang R, van Abel D, van Dijk M, Yang X, et al. Stox1 as a novel transcriptional suppressor of Math1 during cerebellar granule neurogenesis and medulloblastoma formation. Cell Death Differ. 2016.
Chen WS, Zhu HHe, Feng G-S. Treating Leukemia at Risk of Inducing Severe Anemia. Exp Hematol. 2016.
Fan L, Gong Y, He Y, Gao W-Q, Dong X, Dong B, Zhu HHe, Xue W. TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer. Oncogene. 2022.
Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HHe, Gao W-Q. TRIM59 is Upregulated in Gastric Tumors, Promoting Ubiquitination and Degradation of P53. Gastroenterology. 2014.
Wang D, Du G, Chen X, Wang J, Liu K, Zhao H, Cheng C, He Y, Jing N, Xu P, et al. Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer. Cell Death Differ. 2024.